Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04694534
Other study ID # RC-P0066
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 8, 2021
Est. completion date March 1, 2026

Study information

Verified date June 2023
Source Lille Catholic University
Contact Amélie Lausiaux, MD, PhD
Phone 03.20.22.52.69
Email lansiaux.amelie@ghicl.net
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The main goal of this study is to assess the effectiveness of a cognitive remediation program based on a "serious game" on the information processing speed evolution and the process of learning via episodic memory in multiple sclerosis patients.


Description:

Cognitive impairment affects 40 to 70% multiple sclerosis patients. This condition is characterized by slower information processing, associated with deficits in episodic memory, attention and executive functions. These disorders appear early, regardless of functional impairment, in "benign" forms and in clinically isolated syndromes of multiple sclerosis. These disruptions can have a significant impact in the socio-professional and personal life of patients and also in the quality of life (job loss risks, daily activities limitations). Even if these disorders are now well documented, remediation strategies remain less studied. Some studies show that the "training" methods, often used, do not seem suitable for clinical monitoring, with benefits that do not persist over time. Despite their impact on daily life, no specific care for planning abilities, mental inhibition and flexibility, or even social cognition, have been well studied until today. The same is true concerning metacognitive abilities. Finally, remedial techniques are time consuming and difficult to adapt to patients still in professional activity.


Recruitment information / eligibility

Status Recruiting
Enrollment 150
Est. completion date March 1, 2026
Est. primary completion date March 1, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Relapsing-remitting or progressive multiple sclerosis people defined according to Mc Donald's criteria revised in 2005 - Age between = 18 and = 65 years old - Cognitive complaint, with at least one deficient score at the initial neuropsychological examination (<5th percentile of the reference group), one of the scores of which concerns at least one BICAMS test - Have not had a definite relapse for at least 6 weeks - Be at least 4 weeks away from a corticosteroid bolus - Lack of neuroleptic treatment - Patient with an Internet connection - Signed informed consent Exclusion Criteria: - Severe cognitive deficit defined by obtaining a deficit score in more than six cognitive processes at the initial neuropsychological assessment. - Neuropsychological care - Inability to receive oral and written information - Inability to use the software (due in particular to motor and / or sensory difficulties), - Neurological or psychiatric comorbidity, other than MS and anxiodepressive syndrome - Patient with severe anxiodepressive syndrome (BDI> 27) - Participation in an interventional study on cognitive functions - Patient under legal protection, guardianship or curatorship - Pregnant or breastfeeding women

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Serious game
The serious game is accessible via an online platform, on a tablet: 4 20-minutes activities sessions per week must be carried out. The program format in the serious game form makes possible to simultaneously understand a large number of cognitive functions.
Usual HAS care
The control group patients will follow the care they need, according to the HAS recommendations. Non-specific cognitive activities notebooks will be provided to them. They will be instructed to perform the 4 20-minutes sessions per week for 4 months.

Locations

Country Name City State
France CH d'Arras Arras Nord Pas De Calais
France CH LENS Lens Nord Pas De Calais
France CHRU Lille Nord Pas De Calais
France Saint Vincent hospital Lille Nord Pas De Calais
France Saint-Philibert hospital Lomme Nord
France Charles Nicolle Hospital Rouen Normandie

Sponsors (1)

Lead Sponsor Collaborator
Lille Catholic University

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in the California Verbal Learning Test (CVLT) The California Verbal Learning Test (CVLT) begins with the examiner reading a list of 16 words. Patients listen to the list and report as many of the items as possible. Change from baseline at 4 and 10 months
Primary Change in the Brief Visuo-spatial Memory Test (BVMT) In the Brief Visuospatial/lMemory Test six abstract designs are presented for 10 sec. The display is removed from view and patients render the stimuli via pencil on paper manual responses. Each design receives from 0 to 2 points representing accuracy and location. Thus, scores range from 0 to 12. Change from baseline at 4 and 10 months
Primary Change in the Symbol Digit Modalities Test (SDMT) The Symbol Digit Modalities Test (SDMT) presents a series of nine symbols, each paired with a single digit in a key at the top of a standard sheet of paper. Patients are asked to voice the digit associated with each symbol as rapidly as possible for 90 sec. There is a single outcome measure: the number correct. Change from baseline at 4 and 10 months
Secondary Change in the Auditory-verbal spans in direct or reverse order This assessment is required to evaluate short time memory and working memory. Change from baseline at 4 and 10 months
Secondary Change in the Stroop Color-Word Test This assessment is required to evaluate inhibition capacities and sensitivity to interference. Change from baseline at 4 and 10 months
Secondary Change in the Trail Making Test This assessment is required to evaluate cognitive flexibility abilities. Change from baseline at 4 and 10 months
Secondary Change in the Categorical and phonemic verbal fluency test This test is required to evaluate the spontaneous flexibility abilities. Change from baseline at 4 and 10 months
Secondary Change in the Tower of London test This test is required to assess planning capacities. Change from baseline at 4 and 10 months
Secondary Change in the Commission test This test assesses planning skills in a greener context than the Tower of London test. Change from baseline at 4 and 10 months
Secondary Change in the Concentrated Attention Test This assessment is required to evaluate selective attention. Change from baseline at 4 and 10 months
Secondary Change in the Paced Auditory Serial Addition Task (PASAT) This assessment is required to evaluate information processing speed and sustained attention. Change from baseline at 4 and 10 months
Secondary Change in the Mac Nair Scale This self-evaluation is required to assess cognitive complaint. It is a 39-items questionnaire corresponding to symptoms. Every symptom is noted on an ordinal scale in 5 steps.It is a scale with 5 degrees of severity measuring the frequency of disorders as follows: 4 = very often, 3 = often, 2 = sometimes, 1 = rarely, 0 = never. Change from baseline at 4 and 10 months
Secondary Change in the IPA (Participation and Autonomy Impact) Form This test is focused on the subject social participation and autonomy. is a 21-question multiple-choice self-report inventory, one of the most widely used psychometric tests for measuring the severity of depression. The standard cut-off scores are as follows:
0-9: indicates minimal depression 10-18: indicates mild depression 19-29: indicates moderate depression 30-63: indicates severe depression.
Change from baseline at 4 and 10 months
Secondary Change in the BDI-II Scale (Beck Depression Inventory II) This scale is required to assess participants depressive orders. This is a 21-items self-questionnaire. Every item is rated from 0 (no problem) to 3 (maximum symptom severity). The depressive syndrome severity total score presents 4 intensity levels : 0-11 (no depression), 12-19 (mild depression), 20-27 (medium depression), 27 (severe depression). Change from baseline at 4 and 10 months
Secondary Change in the State-Trait Anxiety Inventory (STAI Y) This scale is used to evaluate the participants level anxiety. It is a 20-items questionnaire. The patients identifie the frequency with which they usually feel the symptoms listed on a four-point Likert-type scale variant from 1: "never" on the 1 point side to 4: "always" on the 4 point side.
The overall score varies between 20 and 80.
Change from baseline at 4 and 10 months
Secondary Change in the Visual Analogue Scale for Fatigue This scale allows patients to assess their fatigue. The patients locate their fatigue intensity on a 100-millimeters horizontal line.Using a ruler, the score is determined by measuring the distance (mm) on the 10-cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100. A higher score indicates greater pain intensity. Change from baseline at 4 and 10 months
Secondary Change in the Apparent validity Face validity is based on a subjective assessment of the instrument's validity to assess the patient's attitude towards the tool, its degree of involvement and its acceptability. Change from baseline at 4 and 10 months
Secondary Change in the EDSS score (Expanded disability status scale) This score is required to assess the patients functional and neurological level disability. This scale stretchs from 0 (no complaint and normal examen) to 10 (death caused by MS). The EDSS scale ranges from 0 to 10 in 0.5 unit increments that represent higher levels of disability. Scoring is based on an examination by a neurologist. Change from baseline at 4 and 10 months
Secondary Frequency of game play per Week (in days) This outcome is required to evaluate the instructions observance and play practices. Observance at 4 months
Secondary Game session lenght This outcome is required to evaluate the instructions observance and play practices. Observance at 4 months
Secondary Time spent gaming This outcome is required to evaluate the instructions observance and play practices. Observance at 4 months
Secondary Game performance : tests number per exercise This outcome is required to evaluate the instructions observance and play practices. The performance will be evaluated by the tests number per exercise. Observance at 4 months
Secondary Game performance : difficulty levels This outcome is required to evaluate the instructions observance and play practices. The performance will be evaluated by the difficulty levels. Observance at 4 months
See also
  Status Clinical Trial Phase
Completed NCT05528666 - Risk Perception in Multiple Sclerosis
Completed NCT03608527 - Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis N/A
Recruiting NCT05532943 - Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis Phase 1/Phase 2
Completed NCT02486640 - Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
Completed NCT01324232 - Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Phase 2
Completed NCT04546698 - 5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
Active, not recruiting NCT04380220 - Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
Completed NCT02835677 - Integrating Caregiver Support Into MS Care N/A
Completed NCT03686826 - Feasibility and Reliability of Multimodal Evoked Potentials
Recruiting NCT05964829 - Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis N/A
Withdrawn NCT06021561 - Orofacial Pain in Multiple Sclerosis
Completed NCT03653585 - Cortical Lesions in Patients With Multiple Sclerosis
Recruiting NCT04798651 - Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis N/A
Active, not recruiting NCT05054140 - Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis Phase 2
Completed NCT05447143 - Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis N/A
Recruiting NCT06195644 - Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients Phase 1
Completed NCT04147052 - iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis N/A
Completed NCT03591809 - Combined Exercise Training in Patients With Multiple Sclerosis N/A
Completed NCT03594357 - Cognitive Functions in Patients With Multiple Sclerosis
Completed NCT03269175 - BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies Phase 4